Imperial Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 18 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 52.20 Cr
- Satisfied Charges ₹ 5.00 M
- Revenue Growth -57.93%
- Profit Growth -81.73%
- Ebitda -168.94%
- Net Worth 6.11%
- Total Assets -17.17%
About Imperial Life Sciences
Imperial Life Sciences Private Limited (ILSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 17 June 2006 and has a history of 18 years and seven months. Its registered office is in New Delhi, Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹52.20 Cr. The company has closed loans amounting to ₹5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ritu Gupta, Prem Gupta, Suresh Gupta, and One other member serve as directors at the Company.
Company Details
-
Location
New Delhi, Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U33125DL2006PTC149810
-
Company No.
149810
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Jun 2006
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Imperial Life Sciences Private Limited offer?
Imperial Life Sciences Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Corona Test Kit, Common Disease Medicines, Pharmaceutical Capsules, Medical Consultants & Clinics, Health Care Service, Medical Test Services, Genetic Testing, Preventive Health Care, Blood Testing.
Who are the key members and board of directors at Imperial Life Sciences?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ritu Gupta
|
Director | 04-Jan-2014 | Current |
|
Prem Gupta
|
Director | 17-Jun-2006 | Current |
|
Suresh Gupta
|
Director | 17-Jun-2006 | Current |
|
Neeraj Gupta
|
Director | 17-Jun-2006 | Current |
Financial Performance of Imperial Life Sciences.
Imperial Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 57.93% decrease. The company also saw a substantial fall in profitability, with a 81.73% decrease in profit. The company's net worth moved up by a moderate rise of 6.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Imperial Life Sciences?
In 2023, Imperial Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Genes 2Me Private LimitedRitu Gupta and Neeraj Gupta are mutual person
-
Imperial Biomedic Pvt LtdPrem Gupta and Neeraj Gupta are mutual person
-
Ils FoundationRitu Gupta and Neeraj Gupta are mutual person
Charges (Loans)
₹522.02 M
₹5.00 M
Charges Breakdown by Lending Institutions
- Others : 28.33 Cr
- Axis Bank Limited : 14.49 Cr
- Icici Bank Limited : 4.39 Cr
- Dewan Housing Finance Corporation Limited : 3.52 Cr
- Religare Finvest Limited : 1.48 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Feb 2024 | Others | ₹11.63 Cr | Open |
| 29 Mar 2021 | Axis Bank Limited | ₹14.00 Cr | Open |
| 30 Nov 2019 | Others | ₹7.00 M | Open |
| 30 Nov 2019 | Others | ₹2.00 Cr | Open |
| 14 Aug 2019 | Axis Bank Limited | ₹4.94 M | Open |
How Many Employees Work at Imperial Life Sciences?
Imperial Life Sciences has a workforce of 68 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Imperial Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Imperial Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.